Suppr超能文献

静脉注射托拉塞米在突变型长谷白蛋白缺乏大鼠体内的药代动力学和药效学

Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.

作者信息

Kim Eun J, Lee Myung G

机构信息

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, San 56-1, Shinlim-Dong, Kwanak-Gu, Seoul 151-742, Republic of Korea.

出版信息

Biopharm Drug Dispos. 2003 Jan;24(1):27-35. doi: 10.1002/bdd.333.

Abstract

The importance of plasma protein binding of intravenous furosemide in circulating blood for its urinary excretion and hence its diuretic effects in mutant Nagase analbuminemic rats (NARs, an animal model for human familial analbuminemia) was reported. Based on the furosemide report, the diuretic effects of another loop diuretic, torasemide, could be expected in NARs if plasma protein binding of torasemide is considerable in the rats. This was proven by this study. After intravenous administration of torasemide, 10 mg/kg, to NARs, the plasma protein binding of torasemide was 23.3% in the rats due to binding to alpha- and beta-globulins (this value, 23.3%, was greater than only 12% for furosemide), and hence the percentages of intravenous dose of torasemide excreted in 8-h urine as unchanged drug was 14.9% in the rat (this value was considerably greater than only 7% for furosemide). After intravenous administration of torasemide to NARs, the AUC (301 versus 2680 microg/min/ml) was significantly smaller [due to significantly faster both Cl(r) (4.81 versus 0.386 ml/min/kg) and Cl(nr) (28.3 versus 3.33 ml/min/kg)], terminal half-life (18.3 versus 73.5 min) and mean residence time (6.97 versus 61.8 min) were significantly shorter (due to faster Cl, 33.2 versus 3.74 ml/min/kg), and amount of 8-h urinary excretion of unchanged torasemide (446 versus 323 microg, due to increase in intrinsic renal excretion) was significantly greater than those in control rats. The 8-h urine output and 8-h urinary excretions of sodium and chloride were comparable between two groups of rats although the 8-h urinary excretion of torasemide was significantly greater in NARs. This could be explained by the following. The amount of urinary excretion of torasemide was significantly greater in NARs than that in control rats only between 0 and 30 min urine collection. In both groups of rats, the urinary excretion rate of torasemide during 0-30 min reached an upper plateau with respect to urine flow rate as well urinary excretion rates of sodium and chloride. Therefore, the diuretic effects (8-h urine output and 8-h urinary excretions of sodium and chloride) were not significantly different between the two groups of rats.

摘要

有报道称,静脉注射速尿后,其在循环血液中的血浆蛋白结合对于其经尿液排泄以及在突变的长谷川无白蛋白血症大鼠(NARs,一种人类家族性无白蛋白血症的动物模型)中的利尿作用具有重要意义。基于速尿的报道,如果托拉塞米在大鼠中的血浆蛋白结合率可观,那么在NARs中可预期另一种袢利尿剂托拉塞米具有利尿作用。本研究证实了这一点。给NARs静脉注射10mg/kg托拉塞米后,由于与α-和β-球蛋白结合,托拉塞米在大鼠中的血浆蛋白结合率为23.3%(该值23.3%高于速尿仅12%的值),因此托拉塞米静脉给药剂量中以原形药物形式在8小时尿液中排泄的百分比在大鼠中为14.9%(该值显著高于速尿仅7%的值)。给NARs静脉注射托拉塞米后,AUC(301对2680μg/min/ml)显著更小[因为Cl(r)(4.81对0.386ml/min/kg)和Cl(nr)(28.3对3.33ml/min/kg)均显著更快],末端半衰期(18.3对73.5分钟)和平均驻留时间(6.97对61.8分钟)显著更短(由于Cl更快,33.2对3.74ml/min/kg),且托拉塞米8小时尿液中以原形排泄的量(446对323μg,由于肾内固有排泄增加)显著高于对照大鼠。两组大鼠的8小时尿量以及钠和氯的8小时尿排泄量相当,尽管NARs中托拉塞米的8小时尿排泄量显著更高。这可以通过以下情况来解释。仅在收集0至30分钟尿液期间,NARs中托拉塞米的尿排泄量显著高于对照大鼠。在两组大鼠中,0至30分钟期间托拉塞米的尿排泄率相对于尿流率以及钠和氯的尿排泄率均达到一个上限平台期。因此,两组大鼠的利尿作用(8小时尿量以及钠和氯的8小时尿排泄量)无显著差异。

相似文献

1
3
Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagase analbuminemic rats.
Drug Metab Dispos. 2003 Feb;31(2):194-201. doi: 10.1124/dmd.31.2.194.
4
Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats.
Biopharm Drug Dispos. 2007 Oct;28(7):385-92. doi: 10.1002/bdd.565.
7
Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats.
Life Sci. 2003 Jan 31;72(11):1231-45. doi: 10.1016/s0024-3205(02)02373-1.
9
Pharmacokinetics of drugs in mutant Nagase analbuminemic rats and responses to select diuretics.
J Pharm Pharmacol. 2014 Jan;66(1):2-13. doi: 10.1111/jphp.12158. Epub 2013 Oct 23.

引用本文的文献

1
Role of plasma proteins in pharmacokinetics of micafungin, an antifungal antibiotic, in analbuminemic rats.
Antimicrob Agents Chemother. 2008 Sep;52(9):3454-6. doi: 10.1128/AAC.00396-08. Epub 2008 Jun 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验